Having been away the past few weeks for CaRMS, I was excited to come back to medicine. I started my first day of my CEEP selective in the cardiology clinic. It was nice being able to review some common cardiology topics, such as post-MI management (i.e. dual-antiplatelet therapy, ACE inhibitor, beta-blocker, and high-dose statin) and its intricacies. Some of the more interesting cases that I saw that day were related to aortopathies. I had several patients with cardiovascular co-morbidities who presented with an incidental finding
After reviewing these cases with my team and additional readings, the following is my takeaways for thoracic aortic aneurysms.
Presentation: usually asymptomatic but can result in aortic rupture, dissection, and death.
Etiology:
- Degenerative
- Usually older patients with atherosclerotic risk factors (e.g. smoking, hypertension)
- Genetics: e.g. Marfan, Ehlers-Danlos, Loeys-Dietz syndrome, bicuspid aortic valve
- Consider if family history, physical exam findings in keeping with genetic syndrome, younger patients (no specific cut-off but ~<50 years old).
- Inflammatory: giant cell arteritis, Takayasu arteritis, Behcet's disease, ankylosing spondylitis
Management (in general):
- Consider genetics referral
- Monitor every 6 months until stable then annually with imaging (echo, CT/MR angiography)
- Consider elective surgical management if symptomatic (e.g. malperfusion, compression), ascending aorta diameter >55 mm or annual expansion >5 mm (see guidelines for specifics)
- Evaluate for other aneurysms
- Preventative
- Blood pressure control
- Beta-blocker preferred over ACEi/ARBs
- Target 140/90 or if diabetic, 130/80
- CV risk reduction - smoking cessation, lifestyle modification
- Avoid strenuous and isometric exercises
- Avoid fluoroquinolones - increase risk of aortic dissection/rupture
- Counsel patient on symptoms to watch out for, including sudden chest pain, and need for seeking immediate medical attention.
Reference(s):
Boodhwani, M., Andelfinger, G., Leipsic, J., Lindsay, T., McMurtry, M. S., Therrien, J., & Siu, S. C. (2014). Canadian Cardiovascular Society position statement on the management of thoracic aortic disease. Canadian Journal of Cardiology, 30(6), 577-589.
No comments:
Post a Comment